Asano K, Sakamoto H, Sasaki H, Ochiya T, Yoshida T, Ohishi Y, Machida T, Kakizoe T, Sugimura T, Terada M
Genetics Division, National Cancer Center Research Institute, Tokyo, Japan.
Biochem Biophys Res Commun. 1995 Dec 26;217(3):1169-76. doi: 10.1006/bbrc.1995.2892.
Cyclin D1 is a key regulator of the G1-S transition in cell cycle, and its gene is amplified and overexpressed in many cancers. To address the gene amplification potential of the cells in which the cyclin D1 gene expression is deregulated, we have established NIH3T3 clones with various levels of cyclin D1 transgene message. Those transfectants showed anchorage independent growth and tumorigenicity without in vitro morphological transformation. The degree of the transformed phenotype apparently correlated with the cyclin D1 expression level. Upon selection by N-(phosphonoacetyl)-L-aspartate (PALA), the cyclin D1-transfected NIH3T3 cells showed a higher ability to develop PALA-resistant colonies by amplifying the CAD gene, as compared to the parental NIH3T3 cells.
细胞周期蛋白D1是细胞周期中G1-S期转换的关键调节因子,其基因在许多癌症中发生扩增并过表达。为了研究细胞周期蛋白D1基因表达失调的细胞的基因扩增潜力,我们建立了具有不同水平细胞周期蛋白D1转基因信息的NIH3T3克隆。这些转染细胞表现出不依赖贴壁生长和致瘤性,且没有体外形态转化。转化表型的程度明显与细胞周期蛋白D1的表达水平相关。经N-(膦酰乙酰基)-L-天冬氨酸(PALA)筛选后,与亲本NIH3T3细胞相比,转染细胞周期蛋白D1的NIH3T3细胞通过扩增CAD基因显示出更高的形成PALA抗性集落的能力。